Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?

Joyce McKenzie; Alan Jaap; Stephen Gallagher; Ann Rumley; John R Petrie; Gordon D O Lowe; Naveed Sattar

doi:10.1046/j.1365-2265.2003.01906.x

Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?

Joyce McKenzie, Alan Jaap, Stephen Gallagher, Ann Rumley, John R Petrie, Gordon D O Lowe, Naveed Sattar

College of Medicine and Veterinary Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	682-689
Journal	Clinical Endocrinology
Volume	59
DOIs	https://doi.org/10.1046/j.1365-2265.2003.01906.x
Publication status	Published - 2003

Keywords / Materials (for Non-textual outputs)

Hormone Replacement Therapy
Cardiovascular risk
type 2 diabetes mellitus

Access to Document

10.1046/j.1365-2265.2003.01906.x

Cite this

@article{2f9baa00cf01422ca724020f0eb4897a,

title = "Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? ",

keywords = "Hormone Replacement Therapy, Cardiovascular risk, type 2 diabetes mellitus",

author = "Joyce McKenzie and Alan Jaap and Stephen Gallagher and Ann Rumley and Petrie, {John R} and Lowe, {Gordon D O} and Naveed Sattar",

year = "2003",

doi = "10.1046/j.1365-2265.2003.01906.x",

language = "English",

volume = "59",

pages = "682--689",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes

T2 - potentially safer with respect to vascular risk?

AU - McKenzie, Joyce

AU - Jaap, Alan

AU - Gallagher, Stephen

AU - Rumley, Ann

AU - Petrie, John R

AU - Lowe, Gordon D O

AU - Sattar, Naveed

PY - 2003

Y1 - 2003

KW - Hormone Replacement Therapy

KW - Cardiovascular risk

KW - type 2 diabetes mellitus

U2 - 10.1046/j.1365-2265.2003.01906.x

DO - 10.1046/j.1365-2265.2003.01906.x

M3 - Article

SN - 0300-0664

VL - 59

SP - 682

EP - 689

JO - Clinical Endocrinology

JF - Clinical Endocrinology

ER -